Bio-Medical Devices International is categorized under in Irvine, CA and active since 1988.
Bio-Medical Devices International was established in 1988, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 3391120 by the NAICS.
If you are seeking more information, feel free to contact Nick Herbert, Chief Executive Officer at the company’s single location by writing to 17171 Daimler St, Irvine, California CA 92614 or by phoning (949) 752-9642. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Bio-Medical Devices International |
Contact Person: | Nick Herbert, Chief Executive Officer |
Address: | 17171 Daimler St, Irvine, California 92614 |
Phone Number: | (949) 752-9642 |
Website Address: | bmdi.com |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 1988 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | |
SIC Code: | 3841 |
NAICS Code: | 3391120 |
Share This Business: |
Bio-Medical Devices International was started in 1988 to provide professional under the SIC code 3841 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Nick Herbert, Chief Executive Officer for inquiries that concern Bio-Medical Devices International by calling the company number (949) 752-9642, as your correspondence is most welcome. Additionally, the physical location of the single location of Bio-Medical Devices International can be found at the coordinates 33.70142,-117.85499 as well as the street address 17171 Daimler St in Irvine, California 92614.
For its online presence, you may visit Bio-Medical Devices International’s website at bmdi.com and engage with its social media outlets through on Twitter and on Facebook.